Related Experiment Video
Updated: May 25, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
N-myc downstream regulated gene 1 modulates Wnt-β-catenin signalling and pleiotropically suppresses metastasis
Wen Liu1, Fei Xing, Megumi Iiizumi-Gairani
1Department of Medical Microbiology, Southern Illinois University School of Medicine, Springfield, IL, USA.
Abstract:
Wnt signalling has pivotal roles in tumour progression and metastasis; however, the exact molecular mechanism of Wnt signalling in the metastatic process is as yet poorly defined. Here we demonstrate that the tumour metastasis suppressor gene, NDRG1, interacts with the Wnt receptor, LRP6, followed by blocking of the Wnt signalling, and therefore, orchestrates a cellular network that impairs the metastatic progression of tumour cells. Importantly, restoring NDRG1 expression by a small molecule compound significantly suppressed the capability of otherwise highly metastatic tumour cells to thrive in circulation and distant organs in animal models. In addition, our analysis of clinical cohorts data indicate that Wnt+/NDRG-/LRP+ signature has a strong predictable value for recurrence-free survival of cancer patients. Collectively, we have identified NDRG1 as a novel negative master regulator of Wnt signalling during the metastatic progression, which opens an opportunity to define a potential therapeutic target for metastatic disease.
Insights
NDRG1 acts as a tumor suppressor by blocking Wnt signaling and interacting with LRP6, inhibiting cancer metastasis. Restoring NDRG1 expression reduced tumor spread in animal models, offering a potential therapeutic target for metastatic disease.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Wnt signaling is crucial in tumor progression and metastasis.
- The precise molecular mechanisms of Wnt signaling in metastasis are not fully understood.
Purpose of the Study:
- To elucidate the role of NDRG1 in Wnt signaling during tumor metastasis.
- To identify NDRG1 as a potential therapeutic target for metastatic cancer.
Main Methods:
- Investigated the interaction between NDRG1 and Wnt receptor LRP6.
- Assessed the effect of NDRG1 restoration on tumor metastasis in animal models.
- Analyzed clinical cohort data for Wnt+/NDRG-/LRP+ signature and patient survival.
Main Results:
- NDRG1 interacts with LRP6, inhibiting Wnt signaling and impairing tumor cell metastasis.
- Restoring NDRG1 expression suppressed metastasis in animal models.
- A Wnt+/NDRG-/LRP+ signature predicts recurrence-free survival in cancer patients.
Conclusions:
- NDRG1 is a novel negative regulator of Wnt signaling in metastatic progression.
- NDRG1 represents a potential therapeutic target for combating metastatic disease.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Induced Pluripotent Stem Cells
Somatic cells are...
Abnormal Proliferation